The present invention relates to novel methylene dipiperidine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.

 
Web www.patentalert.com

< 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-- yl}-pyrimidine

> Orally available sphingosine 1-phosphate receptor agonists and antagonists

> Dipeptidyl peptidase inhibitors
~ 00569